Extendicare (EXE) Stock Price, News & Analysis

Company Overview

Extendicare Inc., operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Key Stats

• Today's Range: C$33.50 to C$34.48
• 50-Day Range: C$25.40 to C$34.30
• 52-Week Range: C$12.12 to C$35.62
• Volume: 317,281 shs
• Average Volume: 329,631 shs
• Market Capitalization: C$3.22 billion
• P/E Ratio: 24.96
• Dividend Yield: 1.49%
• Price Target: C$31.89
• Consensus Rating: Buy

Extendicare Stock Analysis - MarketRank™

Extendicare scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Buy

Consensus Rating

Extendicare has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 2 strong buy ratings, 6 buy ratings, no hold ratings, and no sell ratings.

Downside Risk

Extendicare has a consensus price target of C$31.89, representing about 6.0% downside from its current price of C$33.92.

Amount of Analyst Coverage

Extendicare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Extendicare is 24.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.91.

Price to Earnings Ratio vs. Sector

The P/E ratio of Extendicare is 24.96, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.91.

Price to Book Value per Share Ratio

Extendicare has a P/B Ratio of 8.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for EXE.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Extendicare pays a meaningful dividend of 1.50%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Extendicare does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Extendicare is 37.24%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: N/A

News Sentiment

Extendicare has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.

Search Interest

Only 19 people have searched for EXE on MarketBeat in the last 30 days. This is a decrease of -55% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Extendicare insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

20.28% of the stock of Extendicare is held by institutions.

Company Calendar

• Ex-Dividend for 5/15 Dividend: 4/30/2026
• Last Earnings: 5/07/2026
• Record date for 5/15 Dividend: 5/15/2026
• Dividend Payable: 5/15/2026
• Today: 5/23/2026
• Ex-Dividend for 6/15 Dividend: 5/29/2026
• Record date for 6/15 Dividend: 6/15/2026
• Dividend Payable: 6/15/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: TSE:EXE
• CIK: N/A
• Web: www.extendicare.com
• Phone: 905-470-4000
• Fax: N/A
• Employees: 23,000
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Extendicare: C$31.89
• High Price Target: C$39.00
• Low Price Target: C$22.50
• Potential Upside/Downside: -6.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.25
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): C$1.36
• Trailing P/E Ratio: 24.96
• Forward P/E Ratio: 55.29
• P/E Growth: N/A
• Net Income: C$65.46 million
• Net Margins: 6.99%
• Pretax Margin: N/A
• Return on Equity: 45.35%
• Return on Assets: 7.16%

Debt

• Debt-to-Equity Ratio: 82.55
• Current Ratio: 1.44
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: C$1.75 billion
• Price / Sales: 1.84
• Cash Flow: C$10.59 per share
• Price / Cash Flow: 3.20
• Book Value: C$4.12 per share
• Price / Book: 8.23

Miscellaneous

• Outstanding Shares: 94,822,000
• Free Float: N/A
• Market Cap: C$3.22 billion
• Optionable: Not Optionable
• Beta: 1.27